Where does Coherus BioSciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Coherus BioSciences, Inc. ranks #4,610 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Coherus BioSciences, Inc. hold?

Coherus BioSciences, Inc. holds 76 US utility patents granted between 2016 and 2023, spanning 10 technology areas.

What is Coherus BioSciences, Inc.'s Innovation Score?

Coherus BioSciences, Inc. has an Innovation Score of 38.2 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Coherus BioSciences, Inc. focus on?

Coherus BioSciences, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 73 patents, ranking #259 of 7,163 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Coherus BioSciences, Inc.'s patent grant rate increasing or decreasing?

Coherus BioSciences, Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Coherus BioSciences, Inc.'s patents?

Coherus BioSciences, Inc.'s patents average 17.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Coherus BioSciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Coherus BioSciences, Inc.

USPTO PatentsView assignee record - 76 granted patents across 10 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Coherus ranks #4,610 of 49,997 tracked US assignees by granted-patent volume, with 76 patents across 10 technology areas.

#4,610
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.2/100): 17.4
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4610 · US Corporation #4,610 · 76 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 76 grants
TOP-DECILE #4,610/49,997
PHOTO-FINISH Berkshire Grey
CPC-FOCUS A61K · 10 areas
INNOV-THIN 38.2/100
CLAIMS-RICH 17.4 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Berkshire Grey, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Coherus’s 38.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.0 pts (39%) Velocity 1.6 pts (4%) Breadth 11.2 pts (29%) Claim depth 10.5 pts (27%)

Qualcomm Incorporated · highest

85
CA Casyso · near

38
IAV Ingenieurgesells… · near

38
Coherus BioSciences · this assignee

38
U S Smokeless Tobacco · near

38
ICT Integrated… · near

38
3D Lighting… · lowest

7

What this shows Coherus's Innovation Score is 38.2/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Coherus?

Each dot is one of Coherus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Coherus’s own 17.4 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Coherus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Coherus's grants concentrate

Coherus BioSciences, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 96.1% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (17 grants) versus a trough of 4 in 2023. By volume, Coherus sits between Berkshire Grey, Inc. and CytomX Therapeutics, Inc..

Coherus's three-year grant acceleration

From 2019–2021 to 2022–2024, Coherus BioSciences, Inc. moved from 38 to 9 grants (0.24x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Berkshire Grey

76
Bottomline

76
Cascades Canada U…

76
Caterpillar Globa…

76
Conformis

76
Cricut

76
Crimson Trace

76
Cytomx Therapeuti…

76
Coherus Bioscienc… ◀

76

What this shows Coherus holds 76 patents at rank #4,610, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Coherus

By rank, the assignees closest to #4,610 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Coherus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Coherus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Coherus ranks #259 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

U.S. Smokeless Tobacco Company LLC 38 ICT Integrated Circuit Testing Gesellschaft für Halbleiterprüftechnik mbH 38 CA Casyso GMBH 38 IAV GmbH Ingenieurgesellschaft Auto und Verkehr 38

Similar claim depth

Nearest assignees by average claims per patent (17.4 here).

Lehigh University 17.4 avg Caterpillar Paving Products Inc. 17.4 avg Warsaw Orthopedic, Inc. 17.4 avg Mediatek Inc. 17.4 avg

Coherus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Coherus BioSciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	6	7.9%
2017	17	22.4%
2018	6	7.9%
2019	9	11.8%
2020	14	18.4%
2021	15	19.7%
2022	5	6.6%
2023	4	5.3%

Which technologies does Coherus BioSciences, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 73

C07K - Peptides 70

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 64

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 4

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Coherus BioSciences, Inc.'s patent record in context - here's where to go next.

Coherus BioSciences, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 96.1% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #4,610 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Coherus BioSciences, Inc. against Berkshire Grey, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.